Pfizer’s Investigational Drug Flunks Late-Stage For Sickle Cell Disease
Pfizer’s Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned. read more
Read More
Deal Dispatch: BeyondTrust On The Block; NBA Teams, Dr. Phil, Alex Jones In Spotlight
Bain Capital circles Rezil; BeyondTrust up for sale; NBA’s Trail Blazers change hands; Dr. Phil, Alex Jones face bankruptcy drama. read more
Icahn Hedge Fund’s Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited
Carl Icahn’s 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names like CTRI and IFF. read more
Breaking Down Vipshop Holdings: 4 Analysts Share Their Views
Latest Ratings for VIPS Date Firm Action From To Feb 2022 Morgan Stanley Downgrades Overweight Equal-Weight Nov 2021 Benchmark Downgrades Buy Hold Sep 2021 New Street Research Downgrades Buy Neutral View More Analyst Ratings for VIPS View the Latest Analyst Ratings read more
